HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eleni Kampylafka Selected Research

Pain (Aches)

1/2020Secukinumab leads to shifts from stage-based towards response-based disease clusters-comparative data from very early and established psoriatic arthritis.
1/2019Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eleni Kampylafka Research Topics

Disease

5Psoriatic Arthritis
10/2023 - 01/2018
4Inflammation (Inflammations)
02/2024 - 01/2018
2Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023 - 01/2019
2Pain (Aches)
01/2020 - 01/2019
1Arthritis (Polyarthritis)
02/2024
1Experimental Arthritis
02/2024
1Joint Diseases (Joint Disease)
01/2019
1Synovitis
01/2018

Drug/Important Bio-Agent (IBA)

4Interleukin-17 (Interleukin 17)IBA
02/2024 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 01/2019
2secukinumabIBA
01/2020 - 01/2018
1Proteins (Proteins, Gene)FDA Link
02/2024
1RNA (Ribonucleic Acid)IBA
02/2024
1Circulating MicroRNAIBA
10/2023
1MicroRNAs (MicroRNA)IBA
10/2023
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
1Antirheumatic Agents (DMARD)IBA
01/2019
1Ustekinumab (CNTO 1275)FDA Link
01/2019